Spectrum Pharma (SPPI) Tops Q3 EPS by 5c

November 8, 2018 4:01 PM EST

Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.56 million versus the consensus estimate of $24.93 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings